Cleveland Diagnostics is preparing to roll out its newly approved prostate cancer test kit in early 2026, with plans to ...

First and only company with 100 approved and active companion diagnostic indications for next-generation sequencing in the ...

India's diagnostic services market is expected to maintain double-digit growth (~12% CAGR) by FY30, driven by rising ...

The IDEXX Cancer Dx is a new blood-based screening/diagnostic panel aimed at detecting canine lymphoma from serum or whole ...

Rahul Guha, MD & CEO of Thyrocare Technologies, said the group does not plan any further stake sale in Thyrocare, but will ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

Leveraging the profound legacy of Lords Mark Industries, a powerhouse with 25 years of excellence in Security paper, solar & ...

The treatment success rate for cancer patients improves when doctors detect the disease during its initial stages, because ...

Now, if the President had any new symptoms related to the chest, abdomen, or pelvis, advanced imaging might be warranted.

These practical, case-focused sessions at Fetch Long Beach promise to deliver immediate, clinic-ready skills.

Iowa is shifting focus from eradicating chronic wasting disease to instead “mitigating its spread and managing its impacts.” ...